These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 20023248)

  • 1. A clinical pilot study of lignin--ascorbic acid combination treatment of herpes simplex virus.
    Lopez BS; Yamamoto M; Utsumi K; Aratsu C; Sakagami H
    In Vivo; 2009; 23(6):1011-6. PubMed ID: 20023248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An update on short-course intermittent and prevention therapies for herpes labialis.
    Gilbert S; Corey L; Cunningham A; Malkin JE; Stanberry L; Whitley R; Spruance S
    Herpes; 2007 Jun; 14 Suppl 1():13A-18A. PubMed ID: 17877887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of valacyclovir vs acyclovir for the prevention of recurrent herpes simplex virus eye disease: a pilot study.
    Miserocchi E; Modorati G; Galli L; Rama P
    Am J Ophthalmol; 2007 Oct; 144(4):547-51. PubMed ID: 17692271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral and perioral herpes simplex virus type 1 (HSV-1) infection: review of its management.
    Arduino PG; Porter SR
    Oral Dis; 2006 May; 12(3):254-70. PubMed ID: 16700734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Valacyclovir and topical clobetasol gel for the episodic treatment of herpes labialis: a patient-initiated, double-blind, placebo-controlled pilot trial.
    Hull C; McKeough M; Sebastian K; Kriesel J; Spruance S
    J Eur Acad Dermatol Venereol; 2009 Mar; 23(3):263-7. PubMed ID: 19143902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical efficacy of topical docosanol 10% cream for herpes simplex labialis: A multicenter, randomized, placebo-controlled trial.
    Sacks SL; Thisted RA; Jones TM; Barbarash RA; Mikolich DJ; Ruoff GE; Jorizzo JL; Gunnill LB; Katz DH; Khalil MH; Morrow PR; Yakatan GJ; Pope LE; Berg JE;
    J Am Acad Dermatol; 2001 Aug; 45(2):222-30. PubMed ID: 11464183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent herpes labialis: a pilot study of the efficacy of zinc therapy.
    Femiano F; Gombos F; Scully C
    J Oral Pathol Med; 2005 Aug; 34(7):423-5. PubMed ID: 16011612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An international, randomized, double-blind, placebo-controlled, study of valacyclovir for the suppression of herpes simplex virus type 2 genital herpes in newly diagnosed patients.
    Fife KH; Warren TJ; Justus SE; Heitman CK;
    Sex Transm Dis; 2008 Jul; 35(7):668-73. PubMed ID: 18461016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of herpes simplex virus infections with oral lithium carbonate--a possible antiviral activity.
    Amsterdam JD; Maislin G; Hooper MB
    Pharmacotherapy; 1996; 16(6):1070-5. PubMed ID: 8947995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The natural history of recurrent herpes simplex labialis: implications for antiviral therapy.
    Spruance SL; Overall JC; Kern ER; Krueger GG; Pliam V; Miller W
    N Engl J Med; 1977 Jul; 297(2):69-75. PubMed ID: 194157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can clinical trials requiring frequent participant contact be conducted over the Internet? Results from an online randomized controlled trial evaluating a topical ointment for herpes labialis.
    Formica M; Kabbara K; Clark R; McAlindon T
    J Med Internet Res; 2004 Feb; 6(1):e6. PubMed ID: 15111272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One-day regimen of valacyclovir for treatment of recurrent genital herpes simplex virus 2 infection.
    Bavaro JB; Drolette L; Koelle DM; Almekinder J; Warren T; Tyring S; Wald A
    Sex Transm Dis; 2008 Apr; 35(4):383-6. PubMed ID: 18362859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppressive therapy with valacyclovir in early genital herpes: a pilot study of clinical efficacy and herpes-related quality of life.
    Handsfield HH; Warren T; Werner M; Phillips JA
    Sex Transm Dis; 2007 Jun; 34(6):339-43. PubMed ID: 17065847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized clinical trial on the treatment of oral herpes with topical zinc oxide/glycine.
    Godfrey HR; Godfrey NJ; Godfrey JC; Riley D
    Altern Ther Health Med; 2001; 7(3):49-56. PubMed ID: 11347285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Balm mint extract (Lo-701) for topical treatment of recurring herpes labialis.
    Koytchev R; Alken RG; Dundarov S
    Phytomedicine; 1999 Oct; 6(4):225-30. PubMed ID: 10589440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of foscarnet for recurrent orolabial herpes: a multicentre randomized double-blind study.
    Lawee D; Rosenthal D; Aoki FY; Portnoy J
    CMAJ; 1988 Feb; 138(4):329-33. PubMed ID: 2962712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical application of penciclovir cream for the treatment of herpes simplex facialis/labialis: a randomized, double-blind, multicentre, aciclovir-controlled trial.
    Lin L; Chen XS; Cui PG; Wang JB; Guo ZP; Lu NZ; Bi ZG; Jia H; Yang XY;
    J Dermatolog Treat; 2002 Jun; 13(2):67-72. PubMed ID: 12060504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of herpes simplex virus (HSV) infection in recipients of HLA-matched T-lymphocyte-depleted bone marrow allografts.
    Engelhard D; Morag A; Or R; Naparstek E; Cividalli G; Ruchlemer R; Aker M; Maayan S; Slavin S
    Isr J Med Sci; 1988 Mar; 24(3):145-50. PubMed ID: 3286577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study of ocular herpes simplex virus in patients with and without self-reported atopy.
    Rezende RA; Hammersmith K; Bisol T; Lima AL; Webster GF; Freitas JF; Rapuano CJ; Laibson PR; Cohen EJ
    Am J Ophthalmol; 2006 Jun; 141(6):1120-1125. PubMed ID: 16765682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical properties, mode of action, and in vivo anti-herpes activities of a lignin-carbohydrate complex from Prunella vulgaris.
    Zhang Y; But PP; Ooi VE; Xu HX; Delaney GD; Lee SH; Lee SF
    Antiviral Res; 2007 Sep; 75(3):242-9. PubMed ID: 17475343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.